Výsledky vyhľadávania - "Andreas F. Hottinger"

2025 Eberhard F. Mammen Award Announcements: Part I—Most Popular Articles.

Autori: Favaloro, Emmanuel J.

Zdroj: Seminars in Thrombosis & Hemostasis; Jun2025, Vol. 51 Issue 4, p366-380, 15p

Predmety: BIOPROSTHETIC heart valves, DISSEMINATED intravascular coagulation, THROMBOTIC thrombocytopenic purpura, POST-acute COVID-19 syndrome, COVID-19

In silico analysis of the oncogenic role of myoferlin (MYOF) and suggestion of folate as a potential therapeutic for brain cancer in the Caucasian population.

Autori: Muthuchetty, Saanvi

Zdroj: Discover Oncology; 7/15/2025, Vol. 16 Issue 1, p1-12, 12p

Predmety: BRAIN cancer, FOLIC acid, BIOINFORMATICS, DRUG target, GENETIC mutation, CARCINOGENESIS, GENES

Primary diffuse large B-cell lymphoma of the central nervous system identified with CSF biomarkers.

Autori: Loser, Valentin Segot, Amandine de Leval, Laurence a ďalší

Zdroj: BMC Neurology; 7/22/2024, Vol. 24 Issue 1, p1-7, 7p

Predmety: DIFFUSE large B-cell lymphomas, CENTRAL nervous system, IMMUNOGLOBULIN light chains, NUCLEOTIDE sequencing, IMMUNOGLOBULIN genes, BIOMARKERS

Hypnosis-Assisted Awake Craniotomy for Eloquent Brain Tumors: Advantages and Pitfalls.

Autori: Cossu, Giulia Vandenbulcke, Alberto Zaccarini, Sonia a ďalší

Zdroj: Cancers; May2024, Vol. 16 Issue 9, p1784, 14p

Predmety: REMIFENTANIL, DATA analysis, RESEARCH funding, CRANIOTOMY, TREATMENT effectiveness, RETROSPECTIVE studies, MANN Whitney U Test, PROPOFOL, HYPNOTISM, STATISTICS, ANALYSIS of variance, PSYCHOLOGICAL stress, COMPARATIVE studies, PATIENT satisfaction, BRAIN tumors, WAKEFULNESS, ANESTHESIA

Immune checkpoint inhibitor-related myositis and myocarditis: diagnostic pitfalls and imaging contribution in a real-world, institutional case series.

Autori: Vicino, Alex Hottinger, Andreas F. Latifyan, Sofiya a ďalší

Zdroj: Journal of Neurology; Apr2024, Vol. 271 Issue 4, p1947-1958, 12p

Predmety: IMMUNE checkpoint proteins, DRUG side effects, DIAGNOSTIC imaging, MYOSITIS, MYOCARDITIS, IMMUNE checkpoint inhibitors

Glioblastoma in the oldest old: Clinical characteristics, therapy, and outcome in patients aged 80 years and older.

Autori: Stadler, Christina Gramatzki, Dorothee Rhun, Emilie Le a ďalší

Zdroj: Neuro-Oncology Practice; Apr2024, Vol. 11 Issue 2, p132-141, 10p

Predmety: PROPORTIONAL hazards models, KARNOFSKY Performance Status, GLIOBLASTOMA multiforme, OLDER patients

Geografický termín: SWITZERLAND, FRANCE

Prediction of Glioma Grade and IDH Status Using 18 F-FET PET/CT Dynamic and Multiparametric Texture Analysis.

Autori: Hajri, Rami Nicod-Lalonde, Marie Hottinger, Andreas F. a ďalší

Zdroj: Diagnostics (2075-4418); Aug2023, Vol. 13 Issue 15, p2604, 13p

Predmety: TEXTURE analysis (Image processing), GLIOMAS, RECEIVER operating characteristic curves, ISOCITRATE dehydrogenase, REGRESSION analysis

Corrigendum: Efficacy and Safety of Tumor Treating Fields (TTFields) in Elderly Patients With Newly Diagnosed Glioblastoma: Subgroup Analysis of methe Phase 3 EF-14 Clinical Trial.

Autori: Ram, Zvi Kim, Chae-Yong Hottinger, Andreas F. a ďalší

Zdroj: Frontiers in Oncology; 4/12/2022, Vol. 12, p1-3, 3p

Predmety: ELECTRIC field therapy, OLDER patients, GLIOBLASTOMA multiforme, BRAIN tumors, CLINICAL trials

Abstracts to the 42^nd Annual Meeting of the Japan Society for Neuro-Oncology.

Zdroj: Neuro-Oncology Advances; 2024 Supplement, Vol. 6, preceding piv1-iv28, 140p

Cancer Therapy-Induced Encephalitis.

Autori: Desbaillets, Nicolas P. Hottinger, Andreas F.

Zdroj: Cancers; Nov2024, Vol. 16 Issue 21, p3571, 18p

Predmety: TREATMENT of encephalitis, ENCEPHALITIS diagnosis, CEREBROSPINAL fluid examination, THERAPEUTIC use of monoclonal antibodies, SYNDROMES, ADRENOCORTICAL hormones, INTRAVENOUS immunoglobulins, NATALIZUMAB, RISK assessment, DRUG side effects, NEUROTOXICOLOGY, BLOOD testing, IMMUNOTHERAPY, ANTINEOPLASTIC agents, BRAIN, ELECTROENCEPHALOGRAPHY, MAGNETIC resonance imaging, RITUXIMAB, IMMUNE checkpoint inhibitors, CANCER chemotherapy, INTRAVENOUS therapy, DISEASES, ENCEPHALITIS, ALTERNATIVE medicine, TUMORS, IMMUNITY, PLASMA exchange (Therapeutics), DISEASE risk factors, DISEASE complications, SYMPTOMS

Safety and anti-tumor activity of lisavanbulin administered as 48-hour infusion in patients with ovarian cancer or recurrent glioblastoma: a phase 2a study.

Autori: Joerger, Markus Hundsberger, Thomas Haefliger, Simon a ďalší

Zdroj: Investigational New Drugs; Apr2023, Vol. 41 Issue 2, p267-275, 9p

Predmety: RESEARCH, FALLOPIAN tubes, OVARIAN tumors, INTRAVENOUS therapy, CLINICAL trials, GLIOMAS, ANTINEOPLASTIC agents, TREATMENT effectiveness, CANCER patients, PERITONEUM tumors, DISEASE relapse, DESCRIPTIVE statistics, TERMINATION of treatment, PATIENT safety

European Association of Neuro-Oncology (EANO) guidelines for treatment of primary central nervous system lymphoma (PCNSL).

Autori: Hoang-Xuan, Khê Deckert, Martina Ferreri, Andrés J M a ďalší

Zdroj: Neuro-Oncology; Jan2023, Vol. 25 Issue 1, p37-53, 17p

Message From the Editors to Our Reviewers.

Autori: Merino, José G. Ciccarelli, Olga Barkhof, Frederik a ďalší

Zdroj: Neurology; 7/9/2024, Vol. 103 Issue 1, p1-7, 7p

Urgent considerations for the neuro-oncologic treatment of patients with gliomas during the COVID-19 pandemic.

Autori: Mohile, Nimish A Blakeley, Jaishri O Gatson, Na Tosha N a ďalší

Zdroj: Neuro-Oncology; Jul2020, Vol. 22 Issue 7, p912-917, 6p

Acute ischaemic stroke in active cancer versus non‐cancer patients: stroke characteristics, mechanisms and clinical outcomes.

Autori: Costamagna, Gianluca Hottinger, Andreas F. Milionis, Haralampos a ďalší

Zdroj: European Journal of Neurology; Apr2024, Vol. 31 Issue 4, p1-12, 12p

Predmety: ISCHEMIC stroke, STROKE patients, PROPENSITY score matching, CANCER relapse, CEREBROVASCULAR disease, TREATMENT effectiveness, STROKE

Geografický termín: LAUSANNE (Switzerland)

Ischemic Stroke in Cancer: Mechanisms, Biomarkers, and Implications for Treatment.

Autori: Costamagna, Gianluca Navi, Babak B. Beyeler, Morin a ďalší

Zdroj: Seminars in Thrombosis & Hemostasis; Apr2024, Vol. 50 Issue 3, p342-359, 18p

Predmety: ISCHEMIC stroke, CANCER-related mortality, CELL-free DNA, FIBRINOLYTIC agents, EXTRACELLULAR vesicles, CANCER fatigue

Therapy for Diffuse Astrocytic and Oligodendroglial Tumors in Adults: ASCO-SNO Guideline.

Autori: Mohile, Nimish A Messersmith, Hans Gatson, Na Tosha N a ďalší

Zdroj: Neuro-Oncology; Mar2022, Vol. 24 Issue 3, p358-383, 26p

Chemotherapy and diffuse low-grade gliomas: a survey within the European Low-Grade Glioma Network.

Autori: Darlix, Amélie Mandonnet, Emmanuel Freyschlag, Christian F a ďalší

Zdroj: Neuro-Oncology Practice; Aug2019, Vol. 6 Issue 4, p264-273, 10p

Predmety: GLIOMAS, THERAPEUTICS, CANCER chemotherapy, OLIGODENDROGLIOMAS, GROUP psychotherapy, TEMOZOLOMIDE, RADIOTHERAPY

Metabolic and transcriptomic profiles of glioblastoma invasion revealed by comparisons between patients and corresponding orthotopic xenografts in mice.

Autori: Cudalbu, Cristina Bady, Pierre Lai, Marta a ďalší

Zdroj: Acta Neuropathologica Communications; 8/4/2021, Vol. 9 Issue 1, p1-16, 16p

Predmety: GLIOBLASTOMA multiforme, NUCLEAR magnetic resonance spectroscopy, XENOGRAFTS, BRAIN tumors, MAGNETIC resonance imaging, BLOOD-brain barrier

Therapeutic Drug Monitoring of Newer Antiepileptic Drugs: A Randomized Trial for Dosage Adjustment.

Autori: Aícua‐Rapún, Irene André, Pascal Rossetti, Andrea O. a ďalší

Zdroj: Annals of Neurology; Jan2020, Vol. 87 Issue 1, p22-29, 8p

Predmety: DRUG monitoring, CLINICAL drug trials, ANTICONVULSANTS, PHARMACOLOGY, TREATMENT effectiveness, EPILEPSY, RANDOMIZED controlled trials, BLIND experiment, DOSE-effect relationship in pharmacology, STATISTICAL sampling